Joined December 2012
- Tweets 488
- Following 45
- Followers 348
- Likes 67
278 Photos and videos
29 Aug 2023
Sarcoma merits #precisionmedicine all year-round! At @DOMAINtx, we take pride to be working with Pr Antoine Italiano, our leading partner in the @RHUCondor against Sarcoma! Thank you, Pr Italiano, for your commitment to developing novel #immunotherapies
#sarcomaawarenessmonth
1
1
247
31 Jul 2023
Success proven by science 👏 This is our firm belief! Our #precisionresearch & collaborations drive #pharma innovation. As leaders in #GPCR #immunooncology, we deliver cutting-edge cancer treatments. Thank you @Biotech_finance for this great article.
1
1
214
24 Jul 2023
Best-in-class also works for choirs!
👏 Congratulations to 24 @DOMAINtx choristers for incredible performance at the solidarity concert organized by @LesBlousesRoses at the home for elderly. Music can help many of us find comfort and inspiration. #cancertreatment #immunooncology
1
216
18 Jul 2023
@DOMAINtx announces @EPOorg decision to grant a composition of matter #patent in > 15 European countries for its proprietary EP4 receptor antagonist program, including the candidate DT-9081, solidifying company's position as a leading #innovator in the field of #immunooncology
1
2
3
804
13 Jul 2023
@DOMAINtx we believe in the untapped potential of #GPCRs to revolutionize #cancer treatment through #immunotherapy. Thank you @lndavid and @dnatweets for highlighting the #drugdiscovery potential of GPCRs in your recent article
#immunooncology #drugdevelopment #precisionmedicine
1
211
11 Jul 2023
🚲« Bike to work » June challenge is now over:
🎯@DOMAINtx is in the top 10 ➡️ 9th out of 243
🛣️ Distance covered: nearly 10,000 km
❔ approximately 2.53 tons of CO2 emissions avoided = trip from Paris to La Réunion!
Congratulations to the Team!
@CADR67 @strasbourg #Cancer
134
4 Jul 2023
@DOMAINtx #ImmunotherapyMonth saw some major milestones. Our #pressday spotlighted our position as the "#GPCR company" in #immunooncology, unlocking the potential of GPCRs VS cancer. Nominations of DT-9045 & DT-7012 further confirmed our commitment to innovative #cancertreatments
1
107
29 Jun 2023
Proud to announce the nomination of DT-7012, our best-in-class Treg-depleting CCR8 monoclonal #antibody strengthening our #pipeline of immunotherapies targeting #GPCR. With its potential & fast-track development we aim to optimize #immunotherapy effects. #precisionmedicine #IO
1
1
194
28 Jun 2023
Hop on your bike for a greener planet! Kudos Team Domain for the effort on #auboulotavelo2023 & dedication to sustainability. Let's inspire others to join us on this eco-friendly journey. #sustainable #worklifebalance #Auboulotavelo @strasbourg @CADR67
66
1 Jun 2023
June 5-8 I @DOMAINtx team will attend @BIOConvention 2023 in Boston. Reach out to learn more about our pipeline of best-in-class & first-in-class #GPCR-targeting assets in #immunooncology.
#BIO2023 #DrugDevelopment #DrugDesign #PrecisionMedicine #Biotech
94
31 May 2023
Happy to inaugurate our new HQ with friends & partners from our #innovation ecosystem. At @DOMAINtx we push the boundaries of science to unlock new possibilities in cancer while committing to #SustainableDevelopment. Our new building reflects that. Thank you all for your support.
25 May 2023
Inauguration ce soir des nouveaux locaux de Domain Therapeutics au Parc d’Innovation. Une belle histoire de développement d’entreprise, d’innovation et d’esprit d’équipe dans une écosystème fertile, au service de la santé… tous mes vœux ! #innovation #biotech #santé
1
73
17 May 2023
Let’s race for #research against #sarcoma & rare types of #cancer in children & young adults, opportunity to make a donation to @BERGONIE33 & contribute to @RHUCondor combining #precisionmedicine & #immunotherapies for more efficient therapeutic management of sarcoma #patients
16 May 2023
📣 La Course du Petit Prince
Pour aider la recherche contre les sarcomes : cancers rares des enfants et jeunes adultes pour l’institut Bergonié.
klikego.com/inscription/la-c…
112
12 May 2023
How can we increase cancer treatment success rate & cure more #patients?
Join @NeuvilleP at #Bioequity Europe 2023 for #presentation on our approach pioneering #GPCR #immunotherapies for #immunooncology:
15th of May / 10:10am / @TheCCD Dublin
#investments @EBDgroup @BioCentury
1
144
3 May 2023
Don't miss a unique opportunity to meet our CEO @NeuvilleP at #LSXworld Congress 2023, London, May 3-4 & learn about @DOMAINtx #GPCR-based therapies & #precision research to unlock new possibilities in #cancer
#drugdevelopment #partnering @LSXLeaders
2
135
28 Apr 2023
Happy #GOLDENWEEK to our friends & #partners in #Japan!
A special thought to @Ono_pharma_PR, thank you for your recent visit @DOMAINtx allowing to deepen our #collaboration efforts with ONO Pharma & @Michel_Bouvier to develop a #GPCR-based solution for #patients #metabolicdisease
2
139